{"title":"MicroRNA-106a regulates the apoptosis and oxidative stress of porcine trabecular meshwork cells by targeting FAS.","authors":"Junyi Lai, Chen Tan, Yunsheng Qiao, Xinghuai Sun, Junyi Chen","doi":"10.1016/j.exer.2025.110313","DOIUrl":null,"url":null,"abstract":"<p><p>This study investigates the impact of miR-106a on trabecular meshwork (TM) and its potential molecular mechanism, as TM dysfunction due to decreased cell viability is a major pathological feature of POAG. Primary porcine TM (PTM) cells were isolated and exposed to hyperoxic conditions to induce senescence. Through small RNA sequencing and qPCR verification, miR-106a was downregulated in aging PTM cells. The transfection system overexpressing miR-106a in PTM cells was achieved by polydopamine (PDA)/polyethyleneimine (PEI) nanoparticles (PDA/PEI NPs). Proliferation, apoptosis, and antioxidant capacity of PTM cells under normal and H<sub>2</sub>O<sub>2</sub>-treated conditions were assessed using CCK-8, mitochondrial assays, and reactive oxygen species measurements. As a result, Overexpression of miR-106a boosted PTM cell proliferation, dampened apoptosis, and enhanced capacity of antioxidative stress. Western blots were carried out to detect the expression of target genes of miR-106a. Mechanically, the expression of the two predicted target genes, FAS and CASP10, and genes of FAS-mediated signaling pathway were suppressed under normal and oxidative stress conditions. Dual-luciferase reporter results confirmed a direct binding between miR-106a and FAS. Thus, miR-106a promotes PTM cells' viability, suppresses apoptosis and enhances antioxidative stress capacity by targeting FAS in PTM cells. Therefore, our study provides a potential therapeutic target in glaucoma.</p>","PeriodicalId":12177,"journal":{"name":"Experimental eye research","volume":" ","pages":"110313"},"PeriodicalIF":3.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental eye research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.exer.2025.110313","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study investigates the impact of miR-106a on trabecular meshwork (TM) and its potential molecular mechanism, as TM dysfunction due to decreased cell viability is a major pathological feature of POAG. Primary porcine TM (PTM) cells were isolated and exposed to hyperoxic conditions to induce senescence. Through small RNA sequencing and qPCR verification, miR-106a was downregulated in aging PTM cells. The transfection system overexpressing miR-106a in PTM cells was achieved by polydopamine (PDA)/polyethyleneimine (PEI) nanoparticles (PDA/PEI NPs). Proliferation, apoptosis, and antioxidant capacity of PTM cells under normal and H2O2-treated conditions were assessed using CCK-8, mitochondrial assays, and reactive oxygen species measurements. As a result, Overexpression of miR-106a boosted PTM cell proliferation, dampened apoptosis, and enhanced capacity of antioxidative stress. Western blots were carried out to detect the expression of target genes of miR-106a. Mechanically, the expression of the two predicted target genes, FAS and CASP10, and genes of FAS-mediated signaling pathway were suppressed under normal and oxidative stress conditions. Dual-luciferase reporter results confirmed a direct binding between miR-106a and FAS. Thus, miR-106a promotes PTM cells' viability, suppresses apoptosis and enhances antioxidative stress capacity by targeting FAS in PTM cells. Therefore, our study provides a potential therapeutic target in glaucoma.
期刊介绍:
The primary goal of Experimental Eye Research is to publish original research papers on all aspects of experimental biology of the eye and ocular tissues that seek to define the mechanisms of normal function and/or disease. Studies of ocular tissues that encompass the disciplines of cell biology, developmental biology, genetics, molecular biology, physiology, biochemistry, biophysics, immunology or microbiology are most welcomed. Manuscripts that are purely clinical or in a surgical area of ophthalmology are not appropriate for submission to Experimental Eye Research and if received will be returned without review.